Literature DB >> 21398615

Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice.

Xuqing Zhang1, Tania Goel, Laura L Goodfield, Sarah J Muse, Eric T Harvill.   

Abstract

IL-6, a pleiotropic cytokine primarily produced by the innate immune system, has been implicated in the development of acquired immune responses, though its roles are largely undefined and may vary in the context of different diseases. Using a murine model of infection, we established that IL-6 influences the adaptive immune responses against the endemic human respiratory pathogen Bordetella pertussis. IL-6 was induced in the lungs of C57BL/6 mice by B. pertussis. IL-6(-/-) mice showed a protracted infectious course and were less efficiently protected by B. pertussis vaccination than wild-type mice. Abs from IL-6(-/-) mice, though lower in titer, efficiently reduced B. pertussis numbers in IL-6-sufficient mice. Pulmonary leukocyte recruitment and splenic or pulmonary T cell cytokine responses to B. pertussis, including Th1 and Th17 cytokine production, were lower in IL-6(-/-) mice than in wild-type mice. Adoptive transfer of immune wild-type CD4(+) cells ameliorated the defect of IL-6(-/-) mice in the control of B. pertussis numbers. Together, these results reveal the dysregulation of multiple aspects of adaptive immune responses in B. pertussis-infected IL-6(-/-) mice and suggest that IL-6 is involved in regulating Ab generation, pulmonary leukocyte accumulation, and T cell cytokine production in response to B. pertussis as well as the generation of effective vaccine-induced immunity against this pathogen.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398615      PMCID: PMC3618952          DOI: 10.4049/jimmunol.1000594

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

Review 1.  Immunity to Bordetella pertussis.

Authors:  K H Mills
Journal:  Microbes Infect       Date:  2001-07       Impact factor: 2.700

2.  Delayed role of tumor necrosis factor- alpha in overcoming the effects of pertussis toxin.

Authors:  Daniel N Wolfe; Paul B Mann; Anne M Buboltz; Eric T Harvill
Journal:  J Infect Dis       Date:  2007-09-12       Impact factor: 5.226

3.  Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines.

Authors:  D Kube; U Sontich; D Fletcher; P B Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-03       Impact factor: 5.464

4.  Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.

Authors:  S L Hodder; J D Cherry; E A Mortimer; A B Ford; J Gornbein; K Papp
Journal:  Clin Infect Dis       Date:  2000-07-24       Impact factor: 9.079

5.  Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection.

Authors:  E T Harvill; A Preston; P A Cotter; A G Allen; D J Maskell; J F Miller
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Authors:  Josef S Smolen; Andre Beaulieu; Andrea Rubbert-Roth; Cesar Ramos-Remus; Josef Rovensky; Emma Alecock; Thasia Woodworth; Rieke Alten
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

Review 7.  The effects of IL-6 on CD4 T cell responses.

Authors:  Oliver Dienz; Mercedes Rincon
Journal:  Clin Immunol       Date:  2008-10-08       Impact factor: 3.969

8.  Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing.

Authors:  Rachel E Sutherland; Joanna S Olsen; Andrew McKinstry; S Armando Villalta; Paul J Wolters
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

9.  Gamma interferon and interleukin-1 receptor 1 regulate neutrophil recruitment to the corneal stroma in a murine model of Onchocerca volvulus keratitis.

Authors:  Katrin Gentil; Eric Pearlman
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

10.  Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo.

Authors:  Cynthia A Bonville; Caroline M Percopo; Kimberly D Dyer; Jiliang Gao; Calman Prussin; Barbara Foster; Helene F Rosenberg; Joseph B Domachowske
Journal:  BMC Immunol       Date:  2009-03-19       Impact factor: 3.615

View more
  11 in total

1.  Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium.

Authors:  Dana N Mitzel; Richard J Jaramillo; Heather Stout-Delgado; Albert P Senft; Kevin S Harrod
Journal:  J Gen Virol       Date:  2013-10-10       Impact factor: 3.891

2.  Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.

Authors:  Dylan T Boehm; Jesse M Hall; Ting Y Wong; Andrea M DiVenere; Emel Sen-Kilic; Justin R Bevere; Shelby D Bradford; Catherine B Blackwood; Cody M Elkins; Katherine A DeRoos; Mary C Gray; C Garret Cooper; Melinda E Varney; Jennifer A Maynard; Erik L Hewlett; Mariette Barbier; F Heath Damron
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

3.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

4.  Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age.

Authors:  Archana Kulkarni-Munje; Nandini Malshe; Sonali Palkar; Aniket Amlekar; Sanjay Lalwani; Akhilesh Chandra Mishra; Vidya Arankalle
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 5.  Review of the neutrophil response to Bordetella pertussis infection.

Authors:  Joshua C Eby; Casandra L Hoffman; Laura A Gonyar; Erik L Hewlett
Journal:  Pathog Dis       Date:  2015-10-02       Impact factor: 3.951

6.  Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis.

Authors:  Dylan T Boehm; M Allison Wolf; Jesse M Hall; Ting Y Wong; Emel Sen-Kilic; Hayden D Basinger; Sebastian A Dziadowicz; Maria de la Paz Gutierrez; Catherine B Blackwood; Shelby D Bradford; Katherine A Begley; William T Witt; Melinda E Varney; Mariette Barbier; F Heath Damron
Journal:  NPJ Vaccines       Date:  2019-10-03       Impact factor: 7.344

7.  Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.

Authors:  M Allison Wolf; Dylan T Boehm; Megan A DeJong; Ting Y Wong; Emel Sen-Kilic; Jesse M Hall; Catherine B Blackwood; Kelly L Weaver; Claire O Kelly; Caleb A Kisamore; Graham J Bitzer; Justin R Bevere; Mariette Barbier; F Heath Damron
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

8.  Caspase-1-independent interleukin-1β is required for clearance of Bordetella pertussis infections and whole-cell vaccine-mediated immunity.

Authors:  David E Place; Sarah J Muse; Girish S Kirimanjeswara; Eric T Harvill
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

9.  Susceptibility of Human Airway Tissue Models Derived From Different Anatomical Sites to Bordetella pertussis and Its Virulence Factor Adenylate Cyclase Toxin.

Authors:  Rinu Sivarajan; David Komla Kessie; Heike Oberwinkler; Niklas Pallmann; Thorsten Walles; Agmal Scherzad; Stephan Hackenberg; Maria Steinke
Journal:  Front Cell Infect Microbiol       Date:  2021-12-23       Impact factor: 5.293

10.  Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice.

Authors:  Illiassou Hamidou Soumana; Bodo Linz; Kalyan K Dewan; Demba Sarr; Monica C Gestal; Laura K Howard; Amanda D Caulfield; Balázs Rada; Eric T Harvill
Journal:  Emerg Infect Dis       Date:  2021-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.